Lorenzo Alberio

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


218 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | ...
 
Global coagulation assays detect an early prothrombotic state in children with acute lymphoblastic leukemia.
Betticher C., Bertaggia Calderara D., Matthey Guirao E., Gomez F.J., Aliotta A., Lemmel E., Ceppi F., Alberio L., Rizzi M. Journal of thrombosis and haemostasis. Peer-reviewed.
Dabigatran accumulation in acute kidney injury: is more better than less to prevent bleeding? A case report.
Matbouli R., Pantet O., Castioni J., Vakilzadeh N., Alberio L., Hugli O., 2024/07/17. International journal of emergency medicine, 17 (1) p. 91. Peer-reviewed.
 
Bleeding heralding the diagnosis of essential thrombocythemia.
Stalder G., Grandoni F., Alberio L., 2024/05. European journal of internal medicine, 123 pp. 165-166. Peer-reviewed.
 
Intrinsic coagulant potential modulates anticoagulant efficacy of rivaroxaban
Pereira Portela Cindy, Stirnimann Guido, Kröll Dino, Aliotta Alessandro, Veuthey Lucas, Zermatten Maxime G., Alberio Lorenzo, Bertaggia Calderara Debora, 2024/05. Thrombosis Research, 237 pp. 34-36. Peer-reviewed.
 
Increase of Phosphoprotein Expressions in Amotosalen/UVA-Treated Platelet Concentrates.
Muret C., Crettaz D., Alberio L., Prudent M., 2024/04. Transfusion medicine and hemotherapy, 51 (2) pp. 101-110. Peer-reviewed.
 
Ischemic Stroke in Cancer: Mechanisms, Biomarkers, and Implications for Treatment.
Costamagna G., Navi B.B., Beyeler M., Hottinger A.F., Alberio L., Michel P., 2024/04. Seminars in thrombosis and hemostasis, 50 (3) pp. 342-359. Peer-reviewed.
 
Diagnostic value of antibody-induced procoagulant platelets in heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology.
Zlamal J., Aliotta A., Alberio L., Chen V., Bakchoul T., SSC Platelet Immunology of the ISTH, 2024/03. Journal of thrombosis and haemostasis, 22 (3) pp. 860-868. Peer-reviewed.
 
Inhibition of mitochondrial calcium transporters alters adp-induced platelet responses.
Shehwar D., Barki S., Aliotta A., Veuthey L., Bertaggia Calderara D., Alberio L., Alam M.R., 2024/01/22. Molecular biology reports, 51 (1) p. 177. Peer-reviewed.
Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure.
Schönborn L., Esteban O., Wesche J., Dobosz P., Broto M., Puig S.R., Fuhrmann J., Torres R., Serra J., Llevadot R. et al., 2023/12/28. Blood, 142 (26) pp. 2305-2314. Peer-reviewed.
 
Bilan hématologique en cas de fausses couches précoces à répétition : quelles évidences ? [Hematological workup in cases of recurrent early miscarriages: what evidences?]
Choffat D., Legardeur H., Grandoni F., Alberio L., Surbone A., Baud D., Gavillet M., 2023/10/18. Revue medicale suisse, 19 (846) pp. 1911-1914. Peer-reviewed.
 
Comparative analysis of automated cell counts in oncological patients: Reliable results of point of care blood impedance measurements and pitfalls in myelodysplastic neoplasias and acute myeloid leukemias.
Blum S., Costanza M., Coutaz C., Naveiras O., Spertini O., Tsilimidos G., Alberio L., 2023/10. International journal of laboratory hematology, 45 (5) pp. 818-821. Peer-reviewed.
 
Pharmacodynamics Monitoring of Emicizumab in Patients with Hemophilia A.
Bertaggia Calderara D., Marchi Cappelletti R., Batista Mesquita Sauvage A.P., Durual S., Gomez F.J., Zermatten M.G., Aliotta A., Casini A., Alberio L., 2023/10. Thrombosis and haemostasis, 123 (10) pp. 955-965. Peer-reviewed.
 
Développements récents en hématologie, Partie 2
Duchosal Michel A., Alberio Lorenzo, Angelillo-Scherrer Anne, Arber Caroline, Balabanov Stefan, Blum Sabine, Bttcher Steffen, Buser Andreas, Cairoli Anne, Chalandon Yves et al., 2023/08/23. Forum Médical Suisse ‒ Swiss Medical Forum.
 
Développements récents en hématologie, Teil 1
Duchosal Michel A., Alberio Lorenzo, Angelillo-Scherrer Anne, Arber Caroline, Balabanov Stefan, Blum Sabine, Bttcher Steffen, Buser Andreas, Cairoli Anne, Chalandon Yves et al., 2023/08/16. Forum Médical Suisse ‒ Swiss Medical Forum.
 
Insuffisance cardiaque aiguë comme présentation principale d'un syndrome catastrophique des antiphospholipides
Friedrich Bastien P., Burger Raphal, Alberio Lorenzo, Girod Grgoire, Kissling Sbastien, Grandoni Francesco, Graf Guillaume, Ribi Camillo, 2023/08/16. Forum Médical Suisse ‒ Swiss Medical Forum.
 
Eosinophilic Granulomatosis with Polyangiitis after mRNA-1273 SARS-CoV-2 Vaccine.
Mencarelli L., Moi L., Dewarrat N., Monti M., Alberio L., Ringwald M., Swierdzewska K., Panagiotis A., Ribi C., 2023/08/07. Vaccines, 11 (8) p. 1335. Peer-reviewed.
 
Consensus report on markers to distinguish procoagulant platelets from apoptotic platelets: communication from the Scientific and Standardization Committee of the ISTH
Josefsson Emma C., Ramström Sofia, Thaler Johannes, Lordkipanidzé Marie, Agbani Ejaife O., Alberio Lorenzo, Bakchoul Tamam, Bouchard Beth A., Camera Marina, Chen Vivien et al., 2023/08. Journal of Thrombosis and Haemostasis, 21 (8) pp. 2291-2299.
Recommendations for the use of andexanet alfa in the management of bleeding in patients on oral factor Xa inhibitors in Switzerland: Guideline from the Working Party Hemostasis of the Swiss Society of Hematology.
Angelillo-Scherrer A., Casini A., Studt J.D., Gerber B., Alberio L.A., Fontana P., 2023/07/26. Swiss medical weekly, 153 p. 40113. Peer-reviewed.
Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban Calibrator.
Burger A., Studt J.D., Mendez A., Alberio L., Fontana P., Wuillemin W.A., Schmidt A., Graf L., Gerber B., Bovet C. et al., 2023/06/20. Diagnostics, 13 (12) p. 2128. Peer-reviewed.
Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) [Gene therapy of Hemophilia: Recommendations from the German, Austrian, and Swiss Society for Thrombosis and Haemostasis Research (GTH)]
Miesbach W., Oldenburg J., Klamroth R., Eichler H., Koscielny J., Holzhauer S., Holstein K., Hovinga JAK, Alberio L., Olivieri M. et al., 2023/06. Hamostaseologie, 43 (3) pp. 196-207. Peer-reviewed.
Efficacy and Safety of Rivaroxaban for Postoperative Thromboprophylaxis in Patients After Bariatric Surgery: A Randomized Clinical Trial.
Kröll D., Nett P.C., Rommers N., Borbély Y., Deichsel F., Nocito A., Zehetner J., Kessler U., Fringeli Y., Alberio L. et al., 2023/05/01. JAMA network open, 6 (5) pp. e2315241. Peer-reviewed.
Successful outcome of pregnancy post-allogeneic stem cell transplant despite severe RH1 alloimmunization: A case report.
Gavillet M., Rufer N., Grandoni F., Rizzi M., Vulliemoz N., Baud D., Alberio L., Canellini G., Legardeur H., 2023/05. British journal of haematology, 201 (3) pp. 581-584. Peer-reviewed.
Long-Term Consequences of COVID-19: A 1-Year Analysis.
Bamps L., Armenti J.P., Bojan M., Grandbastien B., von Garnier C., Du Pasquier R., Desgranges F., Papadimitriou-Olivgeris M., Alberio L., Preisig M. et al., 2023/04/03. Journal of clinical medicine, 12 (7) p. 2673. Peer-reviewed.
Identification of High Platelet Reactivity Despite ADP P2Y12 Inhibitor Treatment: Two Populations in the Vasodilator-Stimulated Phosphoprotein Assay and Variable PFA-P2Y Shapes of Curve.
Mariethoz C., Scala E., Matthey-Guirao E., Rossel J.B., Gomez F.J., Grandoni F., Marcucci C., Alberio L., 2023/04. TH open, 7 (2) pp. e143-e154. Peer-reviewed.
 
Shall we rethink the timing of epidural anesthesia in anticoagulated obstetrical patients?
Legardeur H., Cuenoud A., Panchaud A., Grandoni F., Mesquita Sauvage A.B., Alberio L., Baud D., Gavillet M., 2023/03. American journal of obstetrics and gynecology, 228 (3) pp. 257-260. Peer-reviewed.
Caplacizumab for treating subacute intra-stent thrombus occurring despite efficacious double anti-platelet treatment and anticoagulation: a case report.
Stalder G., Chatte A., De Rossi N., Yerly P., Alberio L., Eeckhout E., 2023/02. European heart journal. Case reports, 7 (2) pp. ytac497. Peer-reviewed.
How to Solve the Conundrum of Heparin-Induced Thrombocytopenia during Cardiopulmonary Bypass.
Revelly E., Scala E., Rosner L., Rancati V., Gunga Z., Kirsch M., Ltaief Z., Rusca M., Bechtold X., Alberio L. et al., 2023/01/18. Journal of clinical medicine, 12 (3) p. 786. Peer-reviewed.
 
Long-standing thrombocytosis often precedes thromboembolic complications heralding the diagnosis of essential thrombocythemia.
Stalder G., Da Silva W.R., Segot A., Blum S., Grandoni F., Alberio L., 2023/01. European journal of internal medicine, 107 pp. 110-112. Peer-reviewed.
 
Perioperative Management of a Patient With Combined Bernard Soulier syndrome and Storage Pool Disease During On-Pump Cardiac Surgery.
Christophel-Plathier E., Costanza M., Kirsch M., Dulguerov F., Chapuis-Bernasconi C., Bisig B., Verdy F., Mendes V., Rancati V., Alberio L. et al., 2023/01. Journal of cardiothoracic and vascular anesthesia, 37 (1) pp. 90-95. Peer-reviewed.
Thrombophilia and outcomes of venous thromboembolism in older patients.
Méan M., Breakey N., Stalder O., Alberio L., Limacher A., Angelillo-Scherrer A., Fontana P., Beer H.J., Rodondi N., Aujesky D. et al., 2023/01. Research and practice in thrombosis and haemostasis, 7 (1) p. 100015. Peer-reviewed.
 
Gene therapy of Haemophilia: Recommendations from the German, Austrian, and Swiss Society for Thrombosis and Haemostasis Research (GTH) [Erratum: Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH)]
Miesbach W., Oldenburg J., Klamroth R., Eichler H., Koscielny J., Holzhauer S., Holstein K., Hovinga JAK, Alberio L., Olivieri M. et al., 2022/12/21. Hamostaseologie, 43 (3) pp. 196-207. Peer-reviewed.
 
Two novel platelet biotinylation methods and their impact on stored platelet concentrates in a blood bank environment.
Muret C., Crettaz D., Martin A., Aliotta A., Bertaggia Calderara D., Alberio L., Prudent M., 2022/11. Transfusion, 62 (11) pp. 2324-2333. Peer-reviewed.
Combinations of rapid immunoassays for a speedy diagnosis of heparin-induced thrombocytopenia.
Rittener-Ruff L., Marchetti M., Matthey-Guirao E., Grandoni F., Gomez F.J., Alberio L., 2022/10. Journal of thrombosis and haemostasis, 20 (10) pp. 2407-2418. Peer-reviewed.
 
Altered platelet functions during treatment with apremilast for psoriatic arthritis: A case report.
Tsilimidos G., Blum S., Aliotta A., Dumusc A., Alberio L., 2022/09. Current research in translational medicine, 70 (4) p. 103358. Peer-reviewed.
Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study.
Sathanantham V., Alberio L., Bovet C., Fontana P., Gerber B., Graf L., Mendez A., Sauter T.C., Schmidt A., Studt J.D. et al., 2022/07/11. Life, 12 (7) p. 1027. Peer-reviewed.
Managing argatroban in heparin-induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia.
Marchetti M., Barelli S., Gleich T., Gomez F.J., Goodyer M., Grandoni F., Alberio L., 2022/06. British journal of haematology, 197 (6) pp. 766-790. Peer-reviewed.
Pseudoreticulocytosis in a patient with myelodysplastic syndrome.
De Rossi N., Alberio L., Stalder G., 2022/06/01. American journal of hematology, 97 (6) pp. 841-842. Peer-reviewed.
Another piece of knowledge in the puzzle of procoagulant COAT platelets.
Aliotta A., Alberio L., 2022/05. Journal of thrombosis and haemostasis, 20 (5) pp. 1073-1076. Peer-reviewed.
Low COAT platelets are frequent in patients with bleeding disorders of unknown cause (BDUC) and can be enhanced by DDAVP.
Segot A., Adler M., Aliotta A., Matthey-Guirao E., Nagler M., Bertaggia Calderara D., Grandoni F., Gomez F.J., Alberio L., 2022/05. Journal of thrombosis and haemostasis, 20 (5) pp. 1271-1274. Peer-reviewed.
 
A case of livedoid vasculopathy, a thrombotic occlusive vasculopathy
Huot Anais, Maniu Christa-Maria, Bogiatzi Sofia, Hohl Daniel, Alberio Lorenzo, Stalder Gregoire, 2022/03. JEADV Clinical Practice, 1 (1) pp. 45-48. Peer-reviewed.
EBV-positive large B-cell lymphoma with an unusual intravascular presentation and associated haemophagocytic syndrome in an HIV-positive patient: report of a case expanding the spectrum of EBV-positive immunodeficiency-associated lymphoproliferative disorders.
Veloza L., Tsai C.Y., Bisig B., Pantet O., Alberio L., Sempoux C., Cavassini M., de Leval L., 2022/03. Virchows Archiv, 480 (3) pp. 699-705. Peer-reviewed.
Mechanisms Underlying Dichotomous Procoagulant COAT Platelet Generation-A Conceptual Review Summarizing Current Knowledge.
Veuthey L., Aliotta A., Bertaggia Calderara D., Pereira Portela C., Alberio L., 2022/02/25. International journal of molecular sciences, 23 (5) p. 2536. Peer-reviewed.
Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study.
Meihandoest T., Studt J.D., Mendez A., Alberio L., Fontana P., Wuillemin W.A., Schmidt A., Graf L., Gerber B., Amstutz U. et al., 2022. Frontiers in cardiovascular medicine, 9 p. 817826. Peer-reviewed.
Blood coagulation alterations over the first 10 days after severe burn injury
Barbier Jeanne M., Viana Marina V., Pantet Olivier, Alberio Lorenzo, Berger Mette M., 2022/01. Burns Open, 6 (1) pp. 10-18.
 
Multicentre evaluation of 5B9, a monoclonal anti-PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology.
Pouplard C., Rollin J., Vayne C., Charuel N., Ahmadi Z., Alberio L., Azjenberg N., Althaus K., Bakchoul T., Chong B. et al., 2022/01. Journal of thrombosis and haemostasis, 20 (1) pp. 252-259. Peer-reviewed.
Severe Late-Onset Drug-Induced Immune Thrombocytopenia Following IFN β-1a Treatment: A Case Report of a 52-Year-Old Woman with Relapse-Remitting Multiple Sclerosis.
Cisarovsky C., Théaudin M., Bart P.A., Stalder G., Alberio L., 2022. Case reports in hematology, 2022 p. 2767031. Peer-reviewed.
Maladie thromboembolique veineuse et grossesse : diagnostic, traitement et suivi [Venous thromboembolic disease during pregnancy : diagnosis, treatment and follow-up]
Vecchio M., Guenot C., Staubli S., Gavillet M., Alberio L., Mazzolai L., Alatri A., 2021/12/08. Revue medicale suisse, 17 (762) pp. 2135-2138. Peer-reviewed.
 
Anticoagulation of women with congenital heart disease during pregnancy
Rutz Tobias, Eggel-Hort Béatrice, Alberio Lorenzo, Bouchardy Judith, 2021/10. International Journal of Cardiology Congenital Heart Disease, 5 p. 100210.
 
High-Dose Epinephrine Enhances Platelet Aggregation at the Expense of Procoagulant Activity.
Aliotta A., Bertaggia Calderara D., Zermatten M.G., Alberio L., 2021/10. Thrombosis and haemostasis, 121 (10) pp. 1337-1344. Peer-reviewed.
 
High levels of interleukine-6 in ascites prevent ascites reinfusion during hemodialysis.
Halfon M., Artru F., Fraga M., Comte D., Alberio L., Brunet J.F., Fakhouri F., Kissling S., 2021/09. Clinics and research in hepatology and gastroenterology, 45 (5) p. 101734. Peer-reviewed.
A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validation.
Willekens G., Studt J.D., Mendez A., Alberio L., Fontana P., Wuillemin W.A., Schmidt A., Graf L., Gerber B., Bovet C. et al., 2021/06. British journal of haematology, 193 (6) pp. 1203-1212. Peer-reviewed.
 
COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Scharf R.E., Alberio L., 2021/06. Hamostaseologie, 41 (3) pp. 179-182. Peer-reviewed.
 
How would we treat our own heparin-induced thrombocytopenia during cardiac surgery?
Koster A., Erdoes G., Nagler M., Birschmann I., Alberio L., 2021/06. Journal of cardiothoracic and vascular anesthesia, 35 (6) pp. 1585-1593. Peer-reviewed.
 
Thrombotic storm under DOAC treatment in a patient with homozygous antithrombin Budapest III mutation.
Condoluci A., Alberio L., Gomez F.J., Studt J.D., Orlando C., Jochmans K., Gerber B., 2021/05. Thrombosis research, 201 pp. 161-163. Peer-reviewed.
 
Recherche d'anticorps anti-PF4/héparine
Parejas Nomie, Alberio Lorenzo, Kraege Vanessa, 2021/04/13. Forum Médical Suisse ‒ Swiss Medical Forum. Peer-reviewed.
 
GTH 2021: The First Online Experience! Useful for Future Meetings?
Alberio L., 2021/04. Hamostaseologie, 41 (2) pp. 100-102. Peer-reviewed.
 
Décompensation cardiaque, arthralgies et prurit généralisé
Tsilimidos Gerasimos, Grandoni Francesco, Blum Sabine, Alberio Lorenzo, Rotman Samuel, Gavillet Mathilde, 2021/03/30. Forum Médical Suisse ‒ Swiss Medical Forum.
Vitamine B12 en pratique : quand tester ? Comment tester ? Et qui substituer ? [Vitamin B12 in practice: When to test ? How to test ? And who should be treated?]
Bruttin J.P., Gilet P., Grandoni F., Alberio L., Favre L., Gavillet M., 2021/03/24. Revue medicale suisse, 17 (731) pp. 582-587. Peer-reviewed.
 
Acquired haemophilia A in the postpartum and risk of relapse in subsequent pregnancies: A systematic literature review.
Dewarrat N., Gavillet M., Angelillo-Scherrer A., Naveiras O., Grandoni F., Tsakiris D.A., Alberio L., Blum S., 2021/03. Haemophilia, 27 (2) pp. 199-210. Peer-reviewed.
 
Sodium-Calcium Exchanger Reverse Mode Sustains Dichotomous Ion Fluxes Required for Procoagulant COAT Platelet Formation.
Aliotta A., Bertaggia Calderara D., Zermatten M.G., Alberio L., 2021/03. Thrombosis and haemostasis, 121 (3) pp. 309-321. Peer-reviewed.
Thrombocytopathies: Not Just Aggregation Defects-The Clinical Relevance of Procoagulant Platelets.
Aliotta A., Bertaggia Calderara D., Zermatten M.G., Marchetti M., Alberio L., 2021/02/24. Journal of clinical medicine, 10 (5) p. 894. Peer-reviewed.
Heparin-Induced Thrombocytopenia: A Review of New Concepts in Pathogenesis, Diagnosis, and Management.
Marchetti M., Zermatten M.G., Bertaggia Calderara D., Aliotta A., Alberio L., 2021/02/10. Journal of clinical medicine, 10 (4) p. 683. Peer-reviewed.
 
GTH 2021: ACROSS BORDERS.
Alberio L., 2021/02. Hamostaseologie, 41 (1) pp. 5-8. Peer-reviewed.
 
Tissue Factor-Independent Coagulation Correlates with Clinical Phenotype in Factor XI Deficiency and Replacement Therapy.
Bertaggia Calderara D., Zermatten M.G., Aliotta A., Batista Mesquita Sauvage A.P., Carle V., Heinis C., Alberio L., 2021/02. Thrombosis and haemostasis, 121 (2) pp. 150-163. Peer-reviewed.
Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider.
Solari D., Alberio L., Ribi C., Grandoni F., Stalder G., 2021/01. TH open, 5 (1) pp. e8-e13. Peer-reviewed.
Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements.
Meihandoest T., Studt J.D., Mendez A., Alberio L., Fontana P., Wuillemin W.A., Schmidt A., Graf L., Gerber B., Maeder G.M. et al., 2021. Frontiers in cardiovascular medicine, 8 p. 717939. Peer-reviewed.
Characterization of Procoagulant COAT Platelets in Patients with Glanzmann Thrombasthenia.
Aliotta A., Krüsi M., Bertaggia Calderara D., Zermatten M.G., Gomez F.J., Batista Mesquita Sauvage A.P., Alberio L., 2020/12/14. International journal of molecular sciences, 21 (24) p. 9515. Peer-reviewed.
Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab.
Fontana P., Alberio L., Albisetti M., Angelillo-Scherrer A., Asmis L.M., Casini A., Gerber B., Graf L., Hegemann I., Korte W. et al., 2020/12/14. Swiss medical weekly, 150 pp. w20422. Peer-reviewed.
 
Cytokine-directed therapy with tocilizumab for immune checkpoint inhibitor-related hemophagocytic lymphohistiocytosis.
Özdemir B.C., Latifyan S., Perreau M., Fenwick C., Alberio L., Waeber G., Spertini F., de Leval L., Michielin O., Obeid M., 2020/12. Annals of oncology, 31 (12) pp. 1775-1778. Peer-reviewed.
 
GTH 2021: simply online … worth experiencing.
Alberio L., 2020/12. Hamostaseologie, 40 (5) pp. 558-559. Peer-reviewed.
Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19
Zermatten Maxime G., Pantet Olivier, Gomez Francisco, Schneider Antoine, Méan Marie, Mazzolai Lucia, Hugli Olivier, Bart Pierre-Alexandre, Papadimitriou-Olivgeris Matthaios, Alberio Lorenzo, 2020/12. Thrombosis Research, 196 pp. 222-226. Peer-reviewed.
 
Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group.
Fakhouri F., Scully M., Provôt F., Blasco M., Coppo P., Noris M., Paizis K., Kavanagh D., Pène F., Quezada S. et al., 2020/11/05. Blood, 136 (19) pp. 2103-2117. Peer-reviewed.
 
Interprétation du dosage des anticorps anti-phospholipides
Nozic Adnan, Burger Raphael, Alberio Lorenzo, Ribi Camillo, 2020/11/03. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum.
 
A Collection of Jewels.
Alberio L., 2020/11. Hamostaseologie, 40 (4) pp. 399-400. Peer-reviewed.
 
Emicizumab-Induced Seronegative Full-House Lupus Nephritis in a Child.
Chehade H., Cachat F., Beck-Popovic M., Rotman S., Diezi L., Albisetti M., Alberio L., Young G., Rizzi M., 2020/11. Pediatrics, 146 (5) pp. e20200123. Peer-reviewed.
 
How to Capture the Bleeding Phenotype in FXI-Deficient Patients.
Bertaggia Calderara D., Zermatten M.G., Aliotta A., Alberio L., 2020/11. Hamostaseologie, 40 (4) pp. 491-499. Peer-reviewed.
 
The Art of Detecting Antibodies against Factor VIII.
Tiede A., Alberio L., 2020/11. Hamostaseologie, 40 (4) pp. 485-490. Peer-reviewed.
 
Découverte d’une thrombocytopénie isolée [Finding of an isolated thrombocytopenia]
van Ouwenaller François, Alberio Lorenzo, Garnier Antoine, 2020/10/21. Forum Med Suisse, 20 (43-44) pp. 612-614.
 
Anémie hémolytique chronique dépendante de transfusions
Solari Daria, Grandoni Francesco, Alberio Lorenzo, Renella Raffaele, Gavillet Mathilde, 2020/10/20. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum.
Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis.
Fraga M., Moradpour D., Artru F., Romailler E., Tschopp J., Schneider A., Chtioui H., Neerman-Arbez M., Casini A., Alberio L. et al., 2020/10. Journal of hepatology, 73 (4) pp. 967-970. Peer-reviewed.
Utility of the Platelet Function Analyzer in Patients with Suspected Platelet Function Disorders: Diagnostic Accuracy Study.
Kaufmann J., Adler M., Alberio L., Nagler M., 2020/10. TH open, 4 (4) pp. e427-e436. Peer-reviewed.
 
Flow Cytometric Monitoring of Dynamic Cytosolic Calcium, Sodium, and Potassium Fluxes Following Platelet Activation.
Aliotta A., Bertaggia Calderara D., Alberio L., 2020/09. Cytometry. Part A, 97 (9) pp. 933-944. Peer-reviewed.
 
Anticoagulants directs
Krähenbühl Marie, Alberio Lorenzo, Kraege Vanessa, 2020/08/26. Forum Médical Suisse ‒ Swiss Medical Forum. Peer-reviewed.
Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2-infected patient.
Stalder G., Alberio L., 2020/08/13. Blood, 136 (7) p. 915. Peer-reviewed.
Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis.
Zermatten M.G., Fraga M., Calderara D.B., Aliotta A., Moradpour D., Alberio L., 2020/08. JHEP reports, 2 (4) p. 100120. Peer-reviewed.
 
Potential and Limitations of the New P2Y12 Inhibitor, Cangrelor, in Preventing Heparin-Induced Platelet Aggregation During Cardiac Surgery: An In Vitro Study.
Scala E., Gerschheimer C., Gomez F.J., Alberio L., Marcucci C., 2020/08. Anesthesia and analgesia, 131 (2) pp. 622-630. Peer-reviewed.
Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis.
Artru F., Alberio L., Moradpour D., Stalder G., 2020/07/07. BMJ case reports, 13 (7) pp. e236815. Peer-reviewed.
Long‐term safety and efficacy of N8‐GP in previously treated adults and adolescents with hemophilia A: Final results from pathfinder2
Giangrande Paul, Abdul Karim Faraizah, Nemes Laszlo, You Chur Woo, Landorph Andrea, Geybels Milan S., Curry Nicola, 2020/06/16. Journal of Thrombosis and Haemostasis.
 
Does One Dose Really Fit All? On the Monitoring of Direct Oral Anticoagulants: A Review of the Literature.
Moner-Banet T., Alberio L., Bart P.A., 2020/06. Hamostaseologie, 40 (2) pp. 184-200. Peer-reviewed.
 
Hemostatic Alterations in Patients With Cirrhosis: From Primary Hemostasis to Fibrinolysis.
Zermatten M.G., Fraga M., Moradpour D., Bertaggia Calderara D., Aliotta A., Stirnimann G., De Gottardi A., Alberio L., 2020/06. Hepatology, 71 (6) pp. 2135-2148. Peer-reviewed.
 
L’hématologie au temps du COVID-19 [Hematology in the time of COVID-19]
Gavillet M., Rufer N., Grandoni F., Carr Klappert J., Zermatten M.G., Cairoli A., Canellini G., Alberio L., Duchosal M.A., Spertini O. et al., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 823-826. Peer-reviewed.
Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland.
Alberio L., Angelillo-Scherrer A., Asmis L., Casini A., Fontana P., Graf L., Hegemann I., Kremer Hovinga J.A., Korte W., Lecompte T. et al., 2020/04/20. Swiss medical weekly, 150 pp. w20210. Peer-reviewed.
Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss consensus statement by the Working Party Hemostasis.
Casini A., Alberio L., Angelillo-Scherrer A., Fontana P., Gerber B., Graf L., Hegemann I., Korte W., Kremer Hovinga J., Lecompte T. et al., 2020/04/06. Swiss medical weekly, 150 pp. w20247. Peer-reviewed.
 
Rapid and accurate Bayesian diagnosis of heparin-induced thrombocytopenia.
Marchetti M., Barelli S., Zermatten M.G., Monnin-Respen F., Matthey-Guirao E., Nicolas N., Gomez F., Goodyer M., Gerschheimer C., Alberio L., 2020/04/02. Blood, 135 (14) pp. 1171-1184. Peer-reviewed.
 
Comparison of ROTEM Sigma to Standard Laboratory Tests and Development of an Algorithm for the Management of Coagulopathic Bleeding in a Tertiary Center.
Scala E., Coutaz C., Gomez F., Alberio L., Marcucci C., 2020/03. Journal of cardiothoracic and vascular anesthesia, 34 (3) pp. 640-649. Peer-reviewed.
 
Hyper-coagulability in obese patients accurately identified by combinations of global coagulation assay parameters.
Bertaggia Calderara D., Aliotta A., Zermatten M.G., Kröll D., Stirnimann G., Alberio L., 2020/03. Thrombosis research, 187 pp. 91-102. Peer-reviewed.
Thrombin generation in a woman with heterozygous factor V Leiden and combined oral contraceptives: A case report.
Zermatten M.G., Bertaggia Calderara D., Aliotta A., Alberio L., 2020/03. Research and practice in thrombosis and haemostasis, 4 (3) pp. 429-432. Peer-reviewed.
 
Rivaroxaban in patients with mechanical heart valves: A pilot study.
Roost E., Weber A., Alberio L., Englberger L., Reineke D., Keller D., Nagler M., Carrel T., 2020/02. Thrombosis research, 186 pp. 1-6. Peer-reviewed.
 
Accuracy of heparin-induced platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia.
Brodard J., Alberio L., Angelillo-Scherrer A., Nagler M., 2020/01. Thrombosis research, 185 pp. 27-30. Peer-reviewed.
Predicting Venous Thromboembolic Events in Patients with Coronavirus Disease 2019 Requiring Hospitalization: an Observational Retrospective Study by the COVIDIC Initiative in a Swiss University Hospital.
Kampouri E., Filippidis P., Viala B., Méan M., Pantet O., Desgranges F., Tschopp J., Regina J., Karachalias E., Bianchi C. et al., 2020. BioMed research international, 2020 p. 9126148. Peer-reviewed.
 
Pregnancy with Chuvash Polycythaemia and Other Congenital Erythrocytosis.
Dewarrat N., Kaiser J., Baud D., Alberio L., Gavillet M., 2020. Acta haematologica, 143 (1) pp. 69-72. Peer-reviewed.
 
Cardiac Surgery Successfully Managed With Cangrelor in a Patient With Persistent Anti-PF4/Heparin Antibodies 8 Years After Heparin-Induced Thrombocytopenia.
Scala E., Pitta-Gros B., Pantet O., Iafrate M., Kirsch M., Marcucci C., Alberio L., 2019/11. Journal of cardiothoracic and vascular anesthesia, 33 (11) pp. 3073-3077. Peer-reviewed.
 
La TEVAR, un traitement durable des thrombi mobiles de l'aorte descendante?
Kohler Corinne, Wyss Thomas Rudolf, Alberio Lorenzo, Schmidli Jrg, Bhlmann Roman, 2019/10/09. Forum Médical Suisse ‒ Swiss Medical Forum.
 
Systematic review and analysis of efficacy of recombinant factor IX products for prophylactic treatment of hemophilia B in comparison with rIX-FP.
Davis J., Yan S., Matsushita T., Alberio L., Bassett P., Santagostino E., 2019/10. Journal of medical economics, 22 (10) pp. 1014-1021. Peer-reviewed.
Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders.
Adler M., Kaufmann J., Alberio L., Nagler M., 2019/07. Journal of thrombosis and haemostasis, 17 (7) pp. 1104-1112. Peer-reviewed.
Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial.
Poli E.C., Alberio L., Bauer-Doerries A., Marcucci C., Roumy A., Kirsch M., De Stefano E., Liaudet L., Schneider A.G., 2019/04/03. Critical care, 23 (1) p. 108. Peer-reviewed.
 
Agreement between activated partial thromboplastin time and anti-Xa activity in critically ill patients receiving therapeutic unfractionated heparin.
Ratano D., Alberio L., Delodder F., Faouzi M., Berger M.M., 2019/03. Thrombosis research, 175 pp. 53-58. Peer-reviewed.
Direct Oral Anticoagulant Drugs: On the Treatment of Cancer-Related Venous Thromboembolism and their Potential Anti-Neoplastic Effect.
Grandoni F., Alberio L., 2019/01/05. Cancers, 11 (1). Peer-reviewed.
 
Proline 36 of the Factor XIII Activation Peptide Plays a Crucial Role in Substrate Recognition and Zymogen Activation.
Li B., Billur R., Maurer M.C., Kohler H.P., Raddatz Müller P., Alberio L., Schroeder V., 2018/12. Thrombosis and haemostasis, 118 (12) pp. 2037-2045. Peer-reviewed.
 
The effect of bariatric surgery on the direct oral anticoagulant rivaroxaban: the extension study.
Kröll D., Nett P.C., Borbély Y.M., Schädelin S., Bertaggia Calderara D., Alberio L., Stirnimann G., 2018/12. Surgery for obesity and related diseases, 14 (12) pp. 1890-1896. Peer-reviewed.
 
Generation of procoagulant collagen- and thrombin-activated platelets in platelet concentrates derived from buffy coat: the role of processing, pathogen inactivation, and storage.
Bertaggia Calderara D., Crettaz D., Aliotta A., Barelli S., Tissot J.D., Prudent M., Alberio L., 2018/10. Transfusion, 58 (10) pp. 2395-2406. Peer-reviewed.
 
EDTA-related degranulation mimicking Storage Pool Disease.
Amoruso M., Alberio L., Nagy M., 2018/09. American journal of hematology, 93 (9) pp. 1192-1193. Peer-reviewed.
Standardized Management Protocol in Severe Postpartum Hemorrhage: A Single-Center Study.
Colucci G., Helsing K., Biasiutti F.D., Raio L., Schmid P., Tsakiris D.A., Eberle B., Surbek D., Lämmle B., Alberio L., 2018/09. Clinical and applied thrombosis/hemostasis, 24 (6) pp. 884-893. Peer-reviewed.
Do hospital doctors test for thrombophilia in patients with venous thromboembolism?
Samim D., Marques-Vidal P., Alberio L., Waeber G., Méan M., 2018/08. Journal of thrombosis and thrombolysis, 46 (2) pp. 238-243. Peer-reviewed.
 
Circadian variation of ticagrelor-induced platelet inhibition in healthy adulty.
Fournier S., Guenat F., Fournier A., Alberio L., Bonny O., Bertaggia Calderara D., Bardy D., Lauriers N., Harbaoui B., Monney P. et al., 2018/07/01. European heart journal. Cardiovascular pharmacotherapy, 4 (3) pp. 166-171. Peer-reviewed.
 
Reply to: The effect of bariatric surgery on direct-acting oral anticoagulant drug levels.
Kröll D., Alberio L., Stirnimann G., 2018/04. Thrombosis research, 164 pp. 15-16. Peer-reviewed.
 
Effect of Rivaroxaban on thrombin generation in vivo. A study in obese patients.
Bertaggia-Calderara D., Kröll D., Gerschheimer C., Nicolas N., Nett P., Stirnimann G., Alberio L., 2018/02. International journal of laboratory hematology, 40 (1) pp. e11-e14. Peer-reviewed.
The Role of Plasma Transfusion in Massive Bleeding: Protecting the Endothelial Glycocalyx?
Barelli S., Alberio L., 2018. Frontiers in medicine, 5 p. 91. Peer-reviewed.
 
Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?
Méan M., Limacher A., Stalder O., Angelillo-Scherrer A., Alberio L., Fontana P., Beer H.J., Rodondi N., Lämmle B., Aujesky D., 2017/10. The American journal of medicine, 130 (10) pp. 1220.e17-1220.e22. Peer-reviewed.
 
Vox Sanguinis International Forum on platelet cryopreservation.
Cohn C.S., Dumont L.J., Lozano M., Marks D.C., Johnson L., Ismay S., Bondar N., T'Sas F., Yokoyama APH, Kutner J.M. et al., 2017/10. Vox sanguinis, 112 (7) pp. e69-e85. Peer-reviewed.
 
Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels.
Studt J.D., Alberio L., Angelillo-Scherrer A., Asmis L.M., Fontana P., Korte W., Mendez A., Schmid P., Stricker H., Tsakiris D.A. et al., 2017/08. Journal of thrombosis and haemostasis, 15 (8) pp. 1576-1583. Peer-reviewed.
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders
Orsini Sara, Noris Patrizia, Bury Loredana, Heller Paula G., Santoro Cristina, Kadir Rezan A., Butta Nora C., Falcinelli Emanuela, Cid Ana Rosa, Fabris Fabrizio et al., 2017/07. Haematologica, 102 (7) pp. 1192-1203.
 
Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study.
Bulla O., Poncet A., Alberio L., Asmis L.M., Gähler A., Graf L., Nagler M., Studt J.D., Tsakiris D.A., Fontana P., 2017/07. Haemophilia, 23 (4) pp. e335-e339. Peer-reviewed.
 
Pharmacokinetics and pharmacodynamics of single doses of rivaroxaban in obese patients prior to and after bariatric surgery.
Kröll D., Stirnimann G., Vogt A., Lai DLL, Borbély Y.M., Altmeier J., Schädelin S., Candinas D., Alberio L., Nett P.C., 2017/07. British journal of clinical pharmacology, 83 (7) pp. 1466-1475. Peer-reviewed.
 
Protein modelling to understand FGB mutations leading to congenital hypofibrinogenaemia.
Casini A., Vilar R., Beauverd Y., Aslan D., Devreese K., Mondelaers V., Alberio L., Gubert C., de Moerloose P., Neerman-Arbez M., 2017/07. Haemophilia, 23 (4) pp. 583-589. Peer-reviewed.
 
Delayed-onset of procoagulant signalling revealed by kinetic analysis of COAT platelet formation.
Alberio L., Ravanat C., Hechler B., Mangin P.H., Lanza F., Gachet C., 2017/06/02. Thrombosis and haemostasis, 117 (6) pp. 1101-1114. Peer-reviewed.
 
Impact of rivaroxaban on point-of-care assays.
Fontana P., Alberio L., Angelillo-Scherrer A., Asmis L.M., Korte W., Mendez A., Schmid P., Stricker H., Studt J.D., Tsakiris D.A. et al., 2017/05. Thrombosis research, 153 pp. 65-70. Peer-reviewed.
 
Progressive compressive thoracic myelopathy
Peciu-Florianu Iulia, Barges-Coll Juan, Alberio Lorenzo, Wider Christian, Duff John Michael, 2017/05. Journal of Clinical Neuroscience, 39 pp. 223-224.
 
Gray platelet syndrome: Novel mutations of the NBEAL2 gene.
Bottega R., Nicchia E., Alfano C., Glembotsky A.C., Pastore A., Bertaggia-Calderara D., Bisig B., Duchosal M.A., Arbesú G., Alberio L. et al., 2017/02. American journal of hematology, 92 (2) pp. E20-E22. Peer-reviewed.
Rapid immunoassays for diagnosis of heparin-induced thrombocytopenia: Comparison of diagnostic accuracy, reproducibility, and costs in clinical practice.
Bankova A., Andres Y., Horn M.P., Alberio L., Nagler M., 2017. PloS one, 12 (6) pp. e0178289. Peer-reviewed.
 
Do we need antiplatelet therapy in thrombocytosis? Pro. Diagnostic and pathophysiologic considerations for a treatment choice.
Alberio L., 2016/11/07. Hamostaseologie, 36 (4) pp. 227-240. Peer-reviewed.
 
Une douleur abdominale peu ordinaire ...
Freire Silvia, Vollenweider Peter, Alberio Lorenzo, Gavillet Mathilde, 2016/11/01. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (44).
 
Des céphalées trompeuses
Markopoulou Agni, Grandoni Francesco, Waeber Gérard, Alberio Lorenzo, Gavillet Mathilde, Kraege Vanessa, 2016/10/25. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (43) pp. 921-924. Peer-reviewed.
Temps de thromboplastine partiel activé allongé, que faire?
Aslan Nurullah, Alberio Lorenzo, Blum Sabine, 2016/10/11. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (41).
 
Un purpura d'installation rapide...
de Sans Laura, Bart Pierre-Alexandre, Hohl Daniel, Neub Angela, Alberio Lorenzo, Voruz Sophie, 2016/06/21. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (25).
 
Acquired intracoronary ADAMTS13 deficiency and VWF retention at sites of critical coronary stenosis in patients with STEMI.
Pedrazzini G., Biasco L., Sulzer I., Anesini A., Moccetti T., Kremer Hovinga J.A., Alberio L., 2016/06/09. Blood, 127 (23) pp. 2934-2936. Peer-reviewed.
 
Une hyperprotéinémie troublante
Beltraminelli Tim, Casutt Giulia, Alberio Lorenzo, Weber Gérard, Sartori Claudio, 2016/01/26. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (04).
Ruxolitinib in the treatment of polycythemia vera: patient selection and special considerations.
Blum S., Martins F., Alberio L., 2016. Journal of Blood Medicine, 7 pp. 205-215. Peer-reviewed.
 
Safety and efficacy of cryopreserved autologous platelet concentrates in HLA-alloimmunized patients with hematologic malignancies.
Gerber B., Alberio L., Rochat S., Stenner F., Manz M.G., Buser A., Schanz U., Stussi G., 2016. Transfusion, 56 (10) pp. 2426-2437. Peer-reviewed.
 
Thromboembolie und Antikoagulation bei Tumorpatienten []
Grandoni F., Kaiser J., Blum S., Alberio L., 2016. Therapeutische Umschau. Revue therapeutique, 73 (10) pp. 595-604. Peer-reviewed.
 
Thromboembolism in patients with congenital afibrinogenaemia. Long-term observational data and systematic review.
Nagler M., Kremer Hovinga J.A., Alberio L., Peter-Salonen K., von Tengg-Kobligk H., Lottaz D., Neerman-Arbez M., Lämmle B., 2016. Thrombosis and Haemostasis, 116 (4) pp. 722-732. Peer-reviewed.
 
Practical guidelines for Argatroban and Bivalirudin in patients with Heparin-induced Thrombocytopenia.
Colucci G., Nagler M., Klaus N., Conte T., Giabbani E., Alberio L., 2015/09/28. J Translational Science, 1 (2) pp. 37-42. Peer-reviewed.
 
Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort.
Nurden A.T., Pillois X., Fiore M., Alessi M.C., Bonduel M., Dreyfus M., Goudemand J., Gruel Y., Benabdallah-Guerida S., Latger-Cannard V. et al., 2015. Human Mutation, 36 (5) pp. 548-561. Peer-reviewed.
 
Formaldehyde-fixation of platelets for flow cytometric measurement of phosphatidylserine exposure is feasible.
Rochat S., Alberio L., 2015. Cytometry. Part A, 87 (1) pp. 32-36. Peer-reviewed.
 
Pancytopénie avec anémie hémolytique et schizocytes: une approche pragmatique [Pancytopenia, Hemolytic Anemia and Schizocytes: a Pragmatic Approach].
Gökok N., Stalder G., Alberio L., Lamy O., Schwotzer N., 2015. Praxis, 104 (14) pp. 751-754. Peer-reviewed.
Prediction of Post-Weaning Fibrinogen Status during Cardiopulmonary Bypass: An Observational Study in 110 Patients.
Erdoes G., Gerster G., Colucci G., Kaiser H., Alberio L., Eberle B., 2015. Plos One, 10 (5) pp. e0126692. Peer-reviewed.
 
Syndromes myélodysplasiques et auto-immunité [Myelodysplastic syndromes and autoimmunity].
Stalder G., Alberio L., Ribi C., 2015. Revue Médicale Suisse, 11 (469) pp. 820-2, 824-5.
 
A case of EDTA-dependent pseudothrombocytopenia: simple recognition of an underdiagnosed and misleading phenomenon.
Nagler M., Keller P., Siegrist D., Alberio L., 2014. Bmc Clinical Pathology, 14 p. 19. Peer-reviewed.
 
Bilateral periorbital ecchymoses. An often missed sign of amyloid purpura.
Colucci G., Alberio L., Demarmels Biasiutti F., Lämmle B., 2014. Hämostaseologie, 34 (3) pp. 249-252. Peer-reviewed.
 
Decreased generation of procoagulant platelets detected by flow cytometric analysis in patients with bleeding diathesis.
Daskalakis M., Colucci G., Keller P., Rochat S., Silzle T., Biasiutti F.D., Barizzi G., Alberio L., 2014. Cytometry. Part B, Clinical Cytometry, 86 (6) pp. 397-409. Peer-reviewed.
 
The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects.
Colucci G., Stutz M., Rochat S., Conte T., Pavicic M., Reusser M., Giabbani E., Huynh A., Thürlemann C., Keller P. et al., 2014. Blood, 123 (12) pp. 1905-1916. Peer-reviewed.
 
The new direct oral anticoagulants in special indications: rationale and preliminary data in cancer, mechanical heart valves, anti-phospholipid syndrome, and heparin-induced thrombocytopenia and beyond.
Alberio L., 2014. Seminars in Hematology, 51 (2) pp. 152-156. Peer-reviewed.
 
My patient is thrombocytopenic! Is (s)he? Why? And what shall I do? A practical approach to thrombocytopenia.
Alberio L., 2013. Hämostaseologie, 33 (2) pp. 83-94. Peer-reviewed.
 
Questions et réponses sur l'utilisation du rivaroxaban (Xarelto) dans la pratique [Questions and answers regarding the use of rivaroxaban in daily practice].
groupe de travail RivaMoS Suisse, groupe Working Party on Haemostasis de la Société suisse d'hématologie, 2013. Revue Médicale Suisse, 9 (392) pp. 1375-1385. Peer-reviewed.
Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study.
Nagler M., Bachmann L.M., Alberio L., Angelillo-Scherrer A., Asmis L.M., Korte W., Mendez A., Reber G., Stricker H., Tsakiris D.A. et al., 2013. Thrombosis Journal, 11 (1) p. 6. Peer-reviewed.
 
Catastrophic Complications of Intravenous Line Flushing with Unfractionated Heparin
Colucci Giuseppe, Jahns Maximilian, Silzle Tobias, Alberio Lorenzo, 2012. International Journal of Clinical Medicine, 03 (01) pp. 36-39.
 
Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients.
Nellen V., Sulzer I., Barizzi G., Lämmle B., Alberio L., 2012. Haematologica, 97 (1) pp. 89-97. Peer-reviewed.
 
Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests: a study in 9 Swiss laboratories.
Asmis L.M., Alberio L., Angelillo-Scherrer A., Korte W., Mendez A., Reber G., Seifert B., Stricker H., Tsakiris D.A., Wuillemin W.A., 2012. Thrombosis Research, 129 (4) pp. 492-498. Peer-reviewed.
Low-dose recombinant factor VIIa for massive bleeding: a single centre observational cohort study with 73 patients.
Schmid P., Mordasini A., Luginbühl M., Regli B., Kohler H.P., Zimmermann H., Inderbitzin D., Hirt A., Lämmle B., Alberio L., 2011/07/07. Swiss medical weekly, 141 pp. w13213. Peer-reviewed.
 
Laboratory-based ROTEM(®) analysis: implementing pneumatic tube transport and real-time graphic transmission.
Colucci G., Giabbani E., Barizzi G., Urwyler N., Alberio L., 2011. International Journal of Laboratory Hematology, 33 (4) pp. 441-446. Peer-reviewed.
 
Massive muscle haematoma three months after starting vitamin K antagonist therapy for deep-vein thrombosis in an antithrombin deficient patient: another case of factor IX propeptide mutation.
Jahns M., Friess D., Demarmels Biasiutti F., Kremer Hovinga J.A., Alberio L., Oldenburg J., Lämmle B., Colucci G., 2011. Thrombosis and Haemostasis, 106 (2) pp. 381-382. Peer-reviewed.
 
On the dosing of lepirudin.
Alberio L., Lämmle B., 2011. British Journal of Clinical Pharmacology, 72 (4) p. 717. Peer-reviewed.
 
Proteine mit Einfluss auf die Blutgerinnung [Proteins influencing the blood coagulation].
Alberio L., 2011. Therapeutische Umschau. Revue Thérapeutique, 68 (11) pp. 631-640. Peer-reviewed.
 
Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study.
Huber A.W., Raio L., Alberio L., Ghezzi F., Surbek D.V., 2011. Journal of Perinatal Medicine, 40 (1) pp. 43-49. Peer-reviewed.
 
Screening for lupus anticoagulant: improving the performance of the lupus-sensitive PTT-LA.
Luginbühl R., Barizzi G., Sulzer I., Lämmle B., Alberio L., 2011. International Journal of Laboratory Hematology, 33 (2) pp. 168-175. Peer-reviewed.
 
Stability of low molecular weight heparin anti-factor Xa activity in citrated whole blood and plasma.
Birri N., Baumgartner D., Conte T., Huynh A., Weller K., Pavicic M., Reusser M., Siegenthaler I., Barizzi G., Alberio L., 2011. British Journal of Haematology, 155 (5) pp. 629-631. Peer-reviewed.
 
The prothrombin time/international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers--two independent studies.
Poller L., Ibrahim S., Keown M., Pattison A., Jespersen J., European Action On Anticoagulation, 2011. Journal of Thrombosis and Haemostasis, 9 (1) pp. 140-148. Peer-reviewed.
 
Chickenpox is not always benign: postvaricella purpura fulminans requires prompt and aggressive treatment.
Fluri S., Kaczala G.W., Leibundgut K., Alberio L., 2010. Pediatric Emergency Care, 26 (12) pp. 932-934. Peer-reviewed.
 
D-dimers predict stroke subtype when assessed early.
Isenegger J., Meier N., Lämmle B., Alberio L., Fischer U., Nedeltchev K., Gralla J., Kohler H.P., Mattle H.P., Arnold M., 2010. Cerebrovascular Diseases, 29 (1) pp. 82-86. Peer-reviewed.
Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes.
Gabutti Luca, Lucchini Barbara, Marone Claudio, Alberio Lorenzo, Burnier Michel, 2009. BMC Nephrology, 10 p. 7.
 
Does point of care prothrombin time measurement reduce the transfusion of fresh frozen plasma in patients undergoing major surgery? The POC-OP randomized-controlled trial.
Urwyler N., Trelle S., Theiler L., Jüni P., Staub L.P., Luyet C., Alberio L., Stricker K., Greif R., 2009. Trials, 10 p. 107. Peer-reviewed.
 
Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients.
Tschudi M., Lämmle B., Alberio L., 2009. Blood, 113 (11) pp. 2402-2409. Peer-reviewed.
 
Effective therapy with tranexamic acid in a case of chronic disseminated intravascular coagulation with acquired alpha2-antiplasmin deficiency associated with AL amyloidosis.
Colucci G., Alberio L., Jahns M., Keller P., Steiner S., Rüsges-Wolter I., Lämmle B., 2009. Thrombosis and Haemostasis, 102 (6) pp. 1285-1287. Peer-reviewed.
 
Immunosuppressive treatment for acquired haemophilia: current practice and future directions in Germany, Austria and Switzerland.
Tiede A., Huth-Kühne A., Oldenburg J., Grossmann R., Geisen U., Krause M., Brand B., Alberio L., Klamroth R., Spannagl M. et al., 2009. Annals of Hematology, 88 (4) pp. 365-370. Peer-reviewed.
 
Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test?
Urwyler N., Staub L.P., Beran D., Deplazes M., Lord S.J., Alberio L., Theiler L., Greif R., 2009. Thrombosis and Haemostasis, 102 (4) pp. 779-786. Peer-reviewed.
 
Monitoring thrombin generation by electrochemistry: development of an amperometric biosensor screening test for plasma and whole blood.
Thuerlemann C., Haeberli A., Alberio L., 2009. Clinical Chemistry, 55 (3) pp. 505-512. Peer-reviewed.
 
Variability of anti-PF4/heparin antibody results obtained by the rapid testing system ID-H/PF4-PaGIA.
Schneiter S., Colucci G., Sulzer I., Barizzi G., Lämmle B., Alberio L., 2009. Journal of Thrombosis and Haemostasis, 7 (10) pp. 1649-1655. Peer-reviewed.
 
Variability of anti-PF4/heparin antibody results obtained by the rapid testing system ID-H/PF4-PaGIA: a rebuttal.
Köchli A., 2009. Journal of Thrombosis and Haemostasis, 7 (10) pp. 1753-5; author reply 1755-6.
 
"HIT on Trousseau". Double trouble: acquired coagulopathy with femoral artery thrombosis.
Warncke C., Alberio L., Savolainen H., von Allmen R., Baumgartner I., Husmann M., 2008. Vasa. Zeitschrift Für Gefässkrankheiten, 37 (3) pp. 281-284. Peer-reviewed.
 
Erhebung zur immunsuppressiven Therapie der erworbenen Hämophilie in Deutschland, Österreich und der Schweiz
Huth-Kühne A., Oldenburg J., Großmann R., Geisen U., Krause M., Brand B., Alberio L., Klamroth R., Spannagl M., Knöbl P. et al., 2008. Hämostaseologie, 28 (S 01) pp. S29-S30.
 
Heparin-induced thrombocytopenia: some working hypotheses on pathogenesis, diagnostic strategies and treatment.
Alberio L., 2008. Current Opinion in Hematology, 15 (5) pp. 456-464. Peer-reviewed.
 
Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature.
Zürcher M., Sulzer I., Barizzi G., Lämmle B., Alberio L., 2008. Thrombosis and Haemostasis, 99 (2) pp. 416-426. Peer-reviewed.
 
Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature: only a part of the story.
Favaloro E.J., 2008. Thrombosis and Haemostasis, 99 (6) pp. 1122-3; author reply 1123.
 
Quantitative assessment of elevated D-dimers.
Barizzi G., Alberio L., 2007. International Journal of Hematology, 86 (5) pp. 459-460. Peer-reviewed.
 
Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysis.
Kalicki R.M., Aregger F., Alberio L., Lämmle B., Frey F.J., Uehlinger D.E., 2007. Thrombosis and Haemostasis, 98 (6) pp. 1200-1207. Peer-reviewed.
 
Variation in coagulation inhibitors during prolonged sitting: possible pathogenetic mechanisms for travel-associated thrombosis.
Stricker H., Colucci G., Alberio L., Mombelli G., 2006. Journal of Thrombosis and Haemostasis, 4 (4) pp. 900-902. Peer-reviewed.
 
More on: thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia.
Alberio L., Lämmle B., 2005. Journal of Thrombosis and Haemostasis, 3 (7) p. 1549.
 
Thrombotic thrombocytopenic purpura.
Lämmle B., Kremer Hovinga J.A., Alberio L., 2005. Journal of Thrombosis and Haemostasis, 3 (8) pp. 1663-1675. Peer-reviewed.
 
Thrombozytenhemmung und -aktivierung Mechanismen und klinische Implikationen [Platelet inhibition and activation. Mechanisms and clinical implications].
Alberio L., Clemetson K.J., 2005. Herz, 30 (3) pp. 176-180. Peer-reviewed.
 
All platelets are not equal: COAT platelets.
Alberio L., Clemetson K.J., 2004. Current Hematology Reports, 3 (5) pp. 338-343. Peer-reviewed.
 
Dyspnoe bei bekannter Sichelzellanämie [Dyspnea in diagnosed sickle cell anemia].
Armbruster K., Alberio L., Kohler H., Nohl F., 2004. Praxis, 93 (48) pp. 2017-2019. Peer-reviewed.
 
Plasma therapy in thrombotic thrombocytopenic purpura: review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency.
Fontana S., Kremer Hovinga J.A., Studt J.D., Alberio L., Lämmle B., Taleghani B.M., 2004. Seminars in Hematology, 41 (1) pp. 48-59. Peer-reviewed.
 
Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura.
Kremer Hovinga J.A., Studt J.D., Demarmels Biasiutti F., Solenthaler M., Alberio L., Zwicky C., Fontana S., Taleghani B.M., Tobler A., Lämmle B., 2004. Haematologica, 89 (3) pp. 320-324. Peer-reviewed.
 
Thrombotic thrombocytopenic purpura.
Lämmle B., Kremer Hovinga J., Studt J.D., Mansouri Taleghani B., Alberio L., 2004. Hematology Journal, 5 Suppl 3 pp. S6-11. Peer-reviewed.
 
Titre of anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems.
Chilver-Stainer L., Lämmle B., Alberio L., 2004. Thrombosis and Haemostasis, 91 (2) pp. 276-282. Peer-reviewed.
 
von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience.
Kremer Hovinga J.A., Studt J.D., Alberio L., Lämmle B., 2004. Seminars in Hematology, 41 (1) pp. 75-82. Peer-reviewed.
Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory.
Studt J.D., Kremer Hovinga J.A., Alberio L., Bianchi V., Lämmle B., 2003/06/14. Swiss medical weekly, 133 (23-24) pp. 325-332. Peer-reviewed.
 
Acquired von Willebrand syndrome in a myeloproliferative disorder. Case 6.
Baud P., Tobler A., Lämmle B., Alberio L., 2003. Hämostaseologie, 23 (3) pp. 121-124. Peer-reviewed.
 
ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.
Vesely S.K., George J.N., Lämmle B., Studt J.D., Alberio L., El-Harake M.A., Raskob G.E., 2003. Blood, 102 (1) pp. 60-68. Peer-reviewed.
 
Deficiency of ADAMTS-13 in thrombotic and thrombocytopenic purpura
Lämmle B, Kremer Hovinga JA, Studt J-D, Alberio L, 2003. J Thromb Haemost, 1 (9) pp. 2042-2044. Peer-reviewed.
 
Die orale Antikoagulation mit Vitamin K-Antagonisten [Oral anticoagulation with vitamin K antagonists].
Alberio L., 2003. Therapeutische Umschau. Revue Thérapeutique, 60 (1) pp. 5-9. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University